Contact us
Precision Medicine
Formamos profesionales y damos acceso a la salud de alta especialidad de manera incluyente y solidaria.
Conoce más →Son una agrupación de mujeres altruistas comprometidas con el Centro Médico ABC para ayudar a pacientes y visitantes.
Conócelas →Agenda tu estudio de radiología e imagen ahora mismo a través de Whatsapp.
Donar ahora →Muchos pacientes oncológicos pediátricos necesitan transfusiones frecuentes de plaquetas debido a los efectos de la quimioterapia.
Cómo ser donante →9 October 2025
Atrioventricular nodal reentrant tachycardia (AVNRT) is a heart condition characterized by a heart rate faster than normal, usually above 100 beats per minute. Episodes typically begin and end suddenly, forcing the heart to work overtime to pump blood more quickly.
AVNRT occurs when the heart’s electrical impulses move in a circular pattern and re-enter areas they have already passed through. It is the most common type of supraventricular tachycardia and most frequently affects young women.
The condition originates in the atrioventricular (AV) node, which is the connection point of the heart’s conduction system between the atria and the ventricles. Its function is to momentarily slow down the cardiac impulse for a few milliseconds, giving the atria time to contract before the ventricles do.
Although its exact origin is unknown, AVNRT is caused by the presence of additional pathways in the AV node. These pathways are present from birth but cause an arrhythmia after the heart has fully developed, usually when the person is between 20 and 30 years old.
AVNRT is one of the most common forms of paroxysmal supraventricular tachycardia.
Symptoms typically begin suddenly, and the patient may experience rapid and regular palpitations ranging from 150 to 250 beats per minute. The palpitations can be accompanied by a feeling of chest tightness, shortness of breath, dizziness, or a sensation of general weakness.
These episodes frequently occur in young, healthy individuals but can also happen in older adults.
Beyond palpitations, some people may experience anxiety, sweating, and, in severe cases, syncope (a brief loss of consciousness) due to a temporary decrease in cardiac output.
These symptoms usually disappear quickly, just as they began, especially if the episode ends spontaneously or with vagal maneuvers like the Valsalva maneuver.
While AVNRT is not usually a dangerous condition on its own, it can impact a patient’s quality of life and requires medical evaluation to confirm the diagnosis.
The diagnosis of AVNRT is mainly based on an electrocardiogram (ECG), especially if a recording is taken during an episode.
A typical AVNRT ECG shows a regular tachycardia with narrow QRS complexes, which means the heart’s ventricles are contracting quickly and efficiently, along with a high heart rate.
The baseline ECG may be completely normal, so ambulatory monitoring with a 24-hour Holter monitor or event recorders may also be used if episodes are infrequent.
To confirm the diagnosis, an intracardiac electrophysiology study may be used in some cases. This procedure allows the doctor to induce the tachycardia in a controlled environment and map the reentrant circuit in the AV node. This evaluation not only confirms the diagnosis of AVNRT but also helps in planning a definitive treatment.
The treatment for AVNRT varies depending on its frequency and severity. In acute cases, when the tachycardia is ongoing, it can be stopped using vagal maneuvers, such as the Valsalva maneuver or facial immersion in cold water, which help stimulate the vagus nerve and can interrupt the reentrant circuit.
If these maneuvers are not effective, a drug that temporarily blocks conduction through the AV node can be administered intravenously. This safely and quickly stops the tachycardia.
For patients with recurrent episodes or significant symptoms, the most effective definitive treatment is radiofrequency catheter ablation. This minimally invasive procedure destroys the focus of the reentrant circuit in the AV node, leading to a cure in almost all cases. Ablation is a procedure especially used in young people.
At the Arrhythmia Clinic at ABC Medical Center, we can provide you with specialized care. Contact us!
How can we help you?
Ricardo can convey complex medical information in an accessible and friendly way so that all of our patients can understand and benefit from it. In addition, he has an empathetic approach, offering information and practical advice that really makes a difference in people's lives. #lifebringsustogether.
Learn more about Ricardo on LinkedIn
Pay in interest-free monthly installments in Specialty Centers, Check Ups, Diagnostic Tests, and Hospitalization
Get from 3 to 9 interest-free installments* with American Express or 6 installments* when paying with Banamex, BBVA, HSBC, Santander or 12 installments*
when paying with Banamex.
Contact us
Precision Medicine
Error: Contact form not found.
We help you
Send us your request and we will forward it to our specialists. We will get in touch with you very soon.
If you have preferred times to receive our call, please indicate them in your message.
Thank you for contacting us!
Interest-free
months in:
Interest-free
months in:
Specialty Centers
Diagnostic Studies
Check-ups
Hospitalization1
Choose from3 to 9 months when paying with American Express cards 2. Or
6 months when paying with your credit card3 Banamex, BBVA Bancomer, HSBC, Santander.
Or 12 months exclusively when paying with Banamex3
Valid until December 31, 2025. Promotions not cumulative. Subject to restrictions 1. In hospitalization, medical fees are not included. 2. Minimum amount: $1,500 for 3 to 6 months and $3,000 for 7 to 9 months 3. Minimum amount $1,500. (Cards issued abroad are not eligible).
Comparison of COVID-19 vaccines
Pfizer-
BioNTech
Pfizer-BioNTech
What is its effectiveness and what does it refer to?
Vaccine type: mRNA
Effectiveness: 95% after the second dose in the prevention of symptomatic COVID-19.
No Does not contain egg, latex, or preservatives.
How many doses are needed?
Two doses are needed, at least 21 days apart (or up to six weeks apart, if necessary).
Who should or shouldn’t get the vaccine?
People who should receive the vaccine are those over 16 years old.
People who should not receive the vaccine are those who have a history of anaphylactic shock (severe allergy) or who are allergic to any component of this vaccine such as polyethylene glycol (PEG) or polysorbate.
What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, muscle pain, chills, joint pain, fever, nausea, malaise, and swollen lymph nodes.
How long will it take for me to be protected and what does it protect me from?
After 14 days of having the complete scheme (after the administration of the 2nd dose), the protection period is still under study. It protects us from serious COVID-19 or requiring hospitalization.
Moderna
What is its effectiveness and what does it refer to?
Vaccine type: mRNA
Effectiveness: 94.5% after the second dose in the prevention of symptomatic COVID-19.
Does not contain egg, latex, or preservatives.
How many doses are needed?
Two doses are needed, at least 28 days apart (or up to six weeks apart, if necessary).
Who should or shouldn’t get the vaccine?
People who should receive the vaccine are those over 18 years old.
People who should not receive the vaccine are those who have a history of anaphylactic shock (severe allergy) or who are allergic to any component of this vaccine.
What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, muscle pain, chills, joint pain, fever, nausea, and swollen lymph nodes in the arm in which you received the injection.
How long will it take for me to be protected and what does it protect me from?
After 14 days of having the complete scheme (after the administration of the 2nd dose), the protection period is still under study. It protects us from serious COVID-19 or requiring hospitalization.
Janssen/
Johnson
& Johnson
Janssen/ Johnson & Johnson
What is its effectiveness and what does it refer to?
Vector-based vaccine.
Effectiveness: 72.0% in the prevention of symptomatic COVID-19.
85% in the prevention of severe COVID-19.
Does not contain egg, latex, or preservatives./strong>
How many doses are needed?
Only one dose in needed.
Who should or shouldn’t get the vaccine?
People who should receive the vaccine are those over 18 years old.
People who should not receive the vaccine are those who have a history of anaphylactic shock (severe allergy) or who are allergic to any component of this vaccine.
What are the possible side effects of the vaccine?
Pain where the injection was given, headache, fatigue, muscle pain, chills, fever, and nausea.
How long will it take for me to be protected and what does it protect me from?
After 28 days of having the complete scheme (the last dose applied), the protection period is still under study. It protects us from 85% serious COVID-19 or requiring hospitalization.
AstraZeneca
and
Oxford
University
AstraZeneca and Oxford University
What is its effectiveness and what does it refer to?
Adenovirus vector-based vaccine.
Effectiveness: 82% after the second dose in the prevention of symptomatic COVID-19.
How many doses are needed?
Two doses are needed, at least 56 days apart (or up to 84 days apart, if necessary).
Who should or shouldn’t get the vaccine?
People who should receive the vaccine are those over 18 years old.
People who should not receive the vaccine are those who have a history of anaphylactic shock (severe allergy) or who are allergic to any component of this vaccine.
What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, myalgia, arthralgia, and fever, which were mild to moderate in intensity and disappeared within 48 hours of vaccination.
How long will it take for me to be protected and what does it protect me from?
After 14 days of having the complete scheme (after the administration of the 2nd dose), the protection period is still under study. It protects us from serious COVID-19 or requiring hospitalization.
Sputnik V
What is its effectiveness and what does it refer to?
Adenovirus vector-based vaccine.
Effectiveness: 92% after the second dose in the prevention of symptomatic COVID-19.
How many doses are needed?
Two doses are needed, at least 21 days apart (or up to six weeks apart, if necessary).
Who should or shouldn’t get the vaccine?
People who should receive the vaccine are those over 18 years old.
People who should not receive the vaccine are those who have a history of anaphylactic shock (severe allergy) or who are allergic to any component of this vaccine.
What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, myalgia, arthralgia, and fever, which were mild to moderate in intensity and disappeared within 48 hours of vaccination.
How long will it take for me to be protected and what does it protect me from?
After 14 days of having the complete scheme (after the administration of the 2nd dose), the protection period is still under study. It protects us from serious COVID-19 or requiring hospitalization.
Anti-Herpes Zoster
Herpes zoster is a painful, burning rash. It usually appears on one part of the body and can last for several weeks. It can cause long-lasting severe pain and scarring. Bacterial skin infections, weakness, muscle paralysis, hearing or vision loss may occur less frequently. Herpes zoster is caused by the same virus that causes chickenpox. After you have had chickenpox, the virus that caused it remains in the body of nerve cells. Sometimes after many years, the virus becomes active again and causes herpes zoster.
Vaccination is indicated in the following cases:
Scheme type:
Rabies
Human rabies is a viral disease transmitted by the bite of an infected animal. It is characterized by acute encephalomyelitis (an aggressive response of the immune system that destroys the myelin layer of the nerves and alters its function at the level of the brain or spinal cord).
Vaccination is indicated in the following cases:
Scheme type:
There are two types.
1. Pre-exposure scheme, consists of three doses of rabies vaccine:
2. Post-exposure scheme, people not vaccinated against rabies, consists of five doses of rabies vaccine.
* If the individual continues to be at risk of exposure to the disease, revaccination should be considered.
Pneumococcal vaccines
Pneumococcal disease can cause serious infections in the lungs (pneumonia), the bloodstream (bacteremia), and the lining of the brain and spinal cord (meningitis).
Two vaccines help prevent pneumococcal disease:
Vaccination is indicated in the following cases:
Scheme type:
*One dose of Pneumococcal 13 vaccine should be given first, followed by one dose of Pneumococcal 23 vaccine, depending on your age and health.